Share Email Print
cover

Proceedings Paper

Introductory investigations of dermatologic diode laser with wavelengths 975 nm: clinical therapy of Recklinghausen disease and of hemangiomas
Author(s): J. Szymańczyk; W. Cenian; L. Piechowski; M. Sawczak; M. Jędrzejewska-Szczerska; A. Cenian
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

The newly developed pulsed/cw dermatological laser (with wavelengths 975 nm) is applied for therapies requiring deep penetration of tissue e.g. cutaneous (dermal) neurofibroma (Recklinghausen disease) or hemangiomas. As the selected eight patients had been treated previously using pulsed a Nd:YAG laser a comparison of these therapies was possible. The results of cutaneous neurofibroma therapy using diode laser show an improvement compared with the case of Ho:YAG and Nd:YAG laser therapies - however this should be checked for a larger number of patients.

Paper Details

Date Published: 8 December 2016
PDF: 9 pages
Proc. SPIE 10159, Laser Technology 2016: Progress and Applications of Lasers, 101590H (8 December 2016); doi: 10.1117/12.2263511
Show Author Affiliations
J. Szymańczyk, Medical Univ. of Warsaw (Poland)
W. Cenian, Institute of Fluid-Flow Machinery (Poland)
L. Piechowski, Institute of Fluid-Flow Machinery (Poland)
M. Sawczak, Institute of Fluid-Flow Machinery (Poland)
M. Jędrzejewska-Szczerska, Gdansk Univ. of Technology (Poland)
A. Cenian, Institute of Fluid-Flow Machinery (Poland)


Published in SPIE Proceedings Vol. 10159:
Laser Technology 2016: Progress and Applications of Lasers
Ryszard S. Romaniuk; Krzysztof Kopczynski; Jan K. Jabczyński; Zygmunt Mierczyk, Editor(s)

© SPIE. Terms of Use
Back to Top